CHRONIC COMPLICATIONS OF DIABETES AND QUALITY OF LIFE.
Kolarić V, Svirčević V, Bijuk R, Zupančič V.
Acta Clin Croat. 2022 Nov;61(3):520-527. doi: 10.20471/acc.2022.61.03.18.
Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications.
Xiong J, Hu H, Guo R, Wang H, Jiang H.
Front Endocrinol (Lausanne). 2021 Apr 29;12:646233. doi: 10.3389/fendo.2021.646233. eCollection 2021.
Cardiac Autonomic Neuropathy in Diabetes Mellitus.
Agashe S, Petak S.
Methodist Debakey Cardiovasc J. 2018 Oct-Dec;14(4):251-256. doi: 10.14797/mdcj-14-4-251.
Biomarkers in Diabetic Retinopathy.
Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O'Neal DN, Januszewski AS.
Rev Diabet Stud. 2015 Spring-Summer;12(1-2):159-95. doi: 10.1900/RDS.2015.12.159. Epub 2015 Aug 10.
Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats.
Yu S, Cheng Y, Zhang L, Yin Y, Xue J, Li B, Gong Z, Gao J, Mu Y.
Stem Cell Res Ther. 2019 Nov 20;10(1):333. doi: 10.1186/s13287-019-1474-8.
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism.
Eid S, Sas KM, Abcouwer SF, Feldman EL, Gardner TW, Pennathur S, Fort PE.
Diabetologia. 2019 Sep;62(9):1539-1549. doi: 10.1007/s00125-019-4959-1. Epub 2019 Jul 25.
Bone metabolism in diabetes: a clinician's guide to understanding the bone-glucose interplay.
Sheu A, White CP, Center JR.
Diabetologia. 2024 Aug;67(8):1493-1506. doi: 10.1007/s00125-024-06172-x. Epub 2024 May 18.
Approach to the Pediatric Patient: Central Diabetes Insipidus.
Patti G, Napoli F, Fava D, Casalini E, Di Iorgi N, Maghnie M.
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1407-1416. doi: 10.1210/clinem/dgab930.
Cardiac rehabilitation in patients with diabetes.
Campos NA, Palacios GA.
Panminerva Med. 2021 Jun;63(2):184-192. doi: 10.23736/S0031-0808.21.04308-1. Epub 2021 Mar 9.
Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile-onset type 1 diabetes mellitus.
Masuda T, Katakami N, Taya N, Miyashita K, Takahara M, Kato K, Kuroda A, Matsuhisa M, Shimomura I.
J Diabetes Investig. 2022 Sep;13(9):1528-1532. doi: 10.1111/jdi.13819. Epub 2022 May 19.
